Maternal-fetal relationships in corticosteroid metabolism

Area of Science:

• Endocrinology
• Developmental Biology
• Pharmacology

Background:

• Corticosterone is a key hormone in fetal development and stress response.
• Understanding corticosterone transfer and metabolism across the placenta is crucial for fetal health.

Purpose of the Study:

• To quantify corticosterone levels and specific activity in fetal mouse tissues.
• To investigate the enzymatic conversion of corticosterone and its implications for fetal hormone regulation.
• To assess the role of maternal versus fetal adrenal function in maintaining fetal corticosterone levels.

Main Methods:

• Maternal mice were injected with 14C-corticosterone.
• Fetal tissues were analyzed for corticosterone content and specific activity using acetylation and cocrystallization.
• Activity of fetal liver 11beta-hydroxysteroid:NADP oxidoreductase was measured.
• Maternal adrenalectomy was performed to assess fetal adrenal function.

Main Results:

• Fetal corticosterone content varied from 641 to 300 ng/g between gestational days 13 and 17.
• Specific activity of fetal corticosterone was significantly lower than maternal, indicating transfer and metabolism.
• Placenta, head, and liver exhibited distinct patterns of corticosterone metabolism.
• Fetal liver 11beta-hydroxysteroid:NADP oxidoreductase activity increased, converting 11-dehydrocorticosterone to corticosterone, raising fetal corticosterone from 16% to 91%.
• Fetal adrenal glands demonstrated functional capacity post-maternal adrenalectomy.

Conclusions:

• Maternal corticosterone readily crosses the placenta and likely predominates in the fetus.
• Fetal tissues maintain corticosterone levels through distinct enzymatic conversions.
• Fetal adrenal function contributes to corticosterone levels, but maternal supply is significant.